ArticleThe Lancet. Oncology2022
Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic.
Georg Pfeiler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleThe Lancet. Oncology2022
Georg Pfeiler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.